The future of Hyperthermia is Eight Medical's business
develops the most advanced intra-vesical hyperthermia device on the market today. Eight medical is dedicated to advancing the science of hyperthermic delivery, from technology to treatment and fostering collaboration among providers toward improving outcomes for patients.
A promising treatment
Results from multiple clinical studies show that hyperthermia in combination with a selected therapeutic solution is a very promising treatment for patients intolerant or immune for the current standard treatment.
is the 10th most common cancer worldwide (6th in men). Each year an estimated 570k new patients are diagnosed with bladder cancer for the 1st time. About 70 % of new bladder cancer patients has the non-muscle invasive type. Even though the non-muscle invasive type can be treated well, this type has a high recurrence rate after several years.